Characteristics of the spontaneously transformed human endothelial cell line ECV304. I. Multiple chromosomal rearrangements in endothelial cells ECV304

Tsitologiya

Volumn 50, Issue 7, 2008, Pages 568-575

  Yartseva, N M ^a   Fedortseva, R F ^b  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^b All Russian Centre of Emergency and Radiation Medicine   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LINE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; ENDOTHELIUM CELL; HUMAN; KARYOTYPING; POLYPLOIDY; ULTRASTRUCTURE;

CELL LINE, TRANSFORMED; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; ENDOTHELIAL CELLS; HUMANS; KARYOTYPING; POLYPLOIDY;

EID: 51349112430     PISSN: 00413771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Aviv H., Khan M. Y., Skurnick J., Okuda K., Kimura M., Gardner J., Pnolo L., Aviv A. 2001. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis. 159 : 281-287.
6. 2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines. Anticancer Res. 19 : 1827-1832.
7. Brown J., Reading S. J., Jones S., Fitchett C. J., Howl J., Martin A., Longland C. L., Michelangeli F., Dubrova Y. E., Brown C. A. 2000. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/32. Lab. Invest. 80 : 37-45.
8. Bulavin D. V., Tararova N. D., Aksenov N. D., Pospelov V. A., Pospelova T. V. 1999. Deregulation of p53/p21 Cipl/Wafl pathway contributes to polyploidy and apoptosis of ElA+cHa-ras transformed cells after gamma-irradiation. Oncogene. 18 : 5611-5619.
9. Cajero-Juarez M., Avila B., Ochoa A., Garrido-Guerrero E., Varela-Echavarria A., Martinez D., Clapp C. 2002. Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium. Eur. J. Cell Biol. 81 : 1-8.
10. Cockerill G. W., Meyer G., Noack L., Vadas M. A., Gambl I. R. 1994. Characterization of a spontaneously transformed human endothelial cell line. Lab. Invest. 71 : 497-509.
11. Drexler H. G., Quentmeier H., Dirks W. G., Mac Leod R. A. 2002. Bladder carcinoma cell line ECV304 is not a model system for endothelial cells. In Vitro Cell Develop, Biol. Anim. 34 : 185-186.
12. Fadl-Elmula J., Kytola S., Pan Y., Lui W. O., Derienzo G., Forsberg L., Mandahl N., Gorunova L., Bergerheim U. S., Heim S., Larson C. 2001. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis. Int. J. Cancer. 92 : 824-831.
13. 2 checkpoint function in human fibroblasts expressing human papilomavirus type 16 E6 oncoprotein. Oncogene. 16 : 1825-1838.
14. Gnarra J. R., Zhou S., Merrill M. J., Wagner J. R., Krumm A., Papavassiliou E., Oldfield E. H., Klausner R. D., Linehan W. M. 1996. Posat-transcriptional regulation of vascular endothelial growth facror mRNA by the product of the VHL tumor suppresor gene. Proc. Nat. Acad. Sci. USA. 93 : 10 586-10 594.
15. Harding M. A., Arden K. C., Gildea J. W., Gildca J. J., Perlman E. J., Viars C., Theodorescu D. 2002. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method positional expression profiling. Cancer Res. 62 : 6981-6989.
16. Harwell L. H., Kastan M. B. 1994. Cell cycle control and cancer. Science. 266 : 1821-1828.
17. Hughes S. E. 1996. Functional characterization of spontaneously transformed human umbilical vein endothelial cell line ECV-304 : use in an in vitro model of angiogenesis. Exp. Cell Res. 225 : 171-185.
18. Hurst C. D., Fiegier H., Carr P., Williams S., Carter 2004. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene. 23 : 2250-2263.
19. Ide H., Minamishima Y., Eizuru Y., Okada M., Sakihama K., Katsuki T. 1988. Transformation of human endothelial cells by SV40 virions. Microbiol. Immunol. 32 : 45-55.
20. ISCH. 2005. An International System for Human Cytogenetic Nomenclature. Basel.
21. Johnson T. E., Umbenhauer D. R., Hill R., Bradt C., Mueller S. N., Levin E. M., Nichols W. W. 1992. Karyotypic and phcnotypic changes during in vitro aging of human endothelial cells. J. Cell. Physiol. 150 : 17-27.
22. Kaelin W. G. J. 1999. Marry vessels, faulty gene. Nature. 399 : 203-204.
23. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stocken E., Day R. S., III, Johnson B. E., Skolnick M. H. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264 : 436-440.
24. Kondo K., Kaelin W. G. J. 2001. The von Hippcl-Lindau tumor suppressor gene. Exp. Cell Res. 264 : 117-125.
25. Lopez-Pedrera C., Jardi M., Engles-Esteve J., Munoz-Anoves P. 1997. Characterization of tissue factor expression on the human endothelial cell line ECV304. Amer. J. Hematol. 56 : 71-78.
26. Macleod K. 2000. Tumor suppressor genes. Curr. Opin. Genet. Develop. 10 : 81-93.
27. Maxwell P. H., Wiesener M. S., Chang G.-W., Clifford S. C., Vaux E. C., Cockman M. E., Wykoff C. C., Pugh C. W., Maher E. R., Ratcliffe P. J. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399 : 271-275.
28. Mukhopadhyay T., Multani A. S., Roth J. A., Pathak S. 1998. Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis. Oncogene. 17 : 901-906.
29. Nichols W. W., Buynak E. B., Bradt C., Hill R., Aronson M., Jarrell J., Mueller S. N., Levin E. M. 1987. Cytogenetic evaluation of human endothelial cell cultures. J. Cell. Physiol. 32 : 453-462.
30. Nobori T., Mluta K., Wu D. J., Lois M., Takabayashi K., Carson D. 1994. Deletions of cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature. 368 : 753-756.
31. Pandita T. K., Pathak S., Geard C. R. 1995. Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet. Cell Genet. 71 : 86-93.
32. Rhim J. S., Tsai W. P., Chen Z. Q., Chen Z., Van Waes C., Burger A. M., Lautenberger J. A. A. 1998. Human vascular endothelial cell model to study angiogenesis and tumorigencsis. Carcinogenesis. 19 : 673-681.
33. Rocco J. W., Sidransky D. 2001. P16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp. Cell Res. 264 : 42-55.
34. Roussel M. F. 1999. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 18 : 5311-5317.
35. Seabright M. A. 1971. A rapid banding technique for human chromosomes. Lancet. 65 : 101-109.
36. Sherr C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Develop. 12 : 2984-2991.
37. Spruck C. H. 1994. P16 gene in uncultured tumours. Nature. 370 : 183-184.
38. 2-phase checkpoint. Int. J. Radiat. Biol. 78 : 807-819.
39. Suda K., Rothen-Rutishauser B., Gunthert M., Wunderli-Allenspach H. 2001. Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Develop. Biol. Anim. 37 : 505-514.
40. Takahashi K., Sawasaki Y., Hata J., Mukai K., Goto T. 1990. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Develop. Biol. 26 : 265-274.
41. Tokunaga O., Satoh T., Yamasaki F., Wu L. 1998. Multinucleated variant endothelial cells (MVECs) in human aorta: chromocomal aneuploidy and a elevated uptake of LDL. Semin Thromb Hemost. 24 : 279-284.
42. Van Oers J. M., Adam C., Denzinger S., Stoehr R., Bertz S., Zaak D., Stief C., Hofstaedter F., Zwarthoff E. C., van der Kwast T. H., Knuechel R., Hartmann A. 2006. Chromosome 9 deletion are more frequent than FGFR3 mutation flat urothelial hyperplasias of the bladder. Int. J. Cancer. 119 : 1212-1205.
43. Zhang L., Aviv H., Gardner J. P., Okuda K., Patel S., Kimura M., Bardeguez A., Aviv A. 2006. Loss of chromosome 13 in cultured human vascular endothelial cells. Exp. Cell Res. 260 : 357-364.